Deadline for registration of interest was Friday 24th April.
Meeting Date: 21st & 22nd September 2015.
Where: Churchill College, Cambridge.
This two-day meeting, hosted by Susan Galbraith, VP Head AstraZeneca Oncology iMED and Ronald Herbst, VP Research & Development, MedImmune, will take place on 21 – 22 September 2015 at Churchill College, Cambridge.
The meeting will provide an opportunity for scientists from AstraZeneca, MedImmune and the Cambridge scientific community to discuss and present cutting-edge research on a variety of multi-disciplinary cancer research topics spanning pre-clinical, translational and clinical research.
Aimed at PhD students, PostDocs and Group Leaders actively engaged in cancer research, the symposium agenda is designed to enable you to network, make new contacts and identify new opportunities for collaboration.
For more information and to register your interest: